Search results
Results from the WOW.Com Content Network
If fainting spells occur often without a triggering event, syncope may be a sign of an underlying heart disease. [37] In the case where syncope is caused by cardiac disease, the treatment is much more sophisticated than that of vasovagal syncope and may involve pacemakers and implantable cardioverter-defibrillators depending on the precise ...
The underlying mechanism involves the nervous system slowing the heart rate and dilating blood vessels, resulting in low blood pressure and thus not enough blood flow to the brain. [2] Diagnosis is based on the symptoms after ruling out other possible causes. [3] Recovery from a reflex syncope episode happens without specific treatment. [2]
The medical term for fainting, or ataques de nervios, is syncope, which happens when the brain does not receive enough oxygen and there is a brief decrease of blood flowing to the brain. Situational syncope occurs when situations affect the nervous system, such as anxiety, fear, pain, dehydration, hyperventilation, and the use of alcohol or ...
In 2019, Karina Drury was diagnosed with postural orthostatic tachycardia syndrome, POTS
Adams–Stokes syndrome, Stokes–Adams syndrome, Gerbec–Morgagni–Adams–Stokes syndrome or GMAS syndrome is a periodic fainting spell in which there is intermittent complete heart block or other high-grade arrhythmia that results in loss of spontaneous circulation and inadequate blood flow to the brain.
Tori Spelling is shedding some light on several recent health scares that have landed her in the hospital. The 50-year-old Beverly Hills, 90210 star opened up about being hospitalized three nights ...
Heat syncope is fainting or dizziness as a result of overheating (syncope is the medical term for fainting). It is a type of heat illness. The basic symptom of heat syncope is fainting, with or without mental confusion. [1] Heat syncope is caused by peripheral vessel dilation, resulting in diminished blood flow to the brain and dehydration.
Studies have shown that a GLP-1 drug, exenatide, sufficiently crosses the blood-brain barrier in rodent models of Parkinson’s disease, leading to improvements in motor performance, behavior ...